NYSEMKT: LGCYLegacy Education Inc Stock
$11.03+0.03 (+0.27%)
Updated Jun 25, 2026
LGCY Price
$11.03
Fair Value Price
$6.19
Market Cap
$139.55M
52 Week Low
$7.94
52 Week High
$14.70
P/E
16.46x
P/B
2.82x
P/S
2.03x
PEG
3.02x
Dividend Yield
N/A
Revenue
$77.90M
Earnings
$8.49M
Gross Margin
47.2%
Operating Margin
15.96%
Profit Margin
10.9%
Debt to Equity
0.52
Operating Cash Flow
$6M
Beta
1.06
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
LGCY Overview
Legacy Education Inc. provides education services to students, high school graduates, and working parents in the United States. The company offers degree programs, including Ultrasound Technician, Cardiac Sonography, and Vocational Nursing Associate of Applied Science degree, Associate Degree of Nursing; and diploma, avocational, and certificate programs, such as Clinical Medical Assisting, Dental Assisting, Medical Administrative Assisting, Medical Billing and Coding, Pharmacy Technician, Veterinary Assistant, Vocational Nursing, Phlebotomy Technician, Magnetic Resonance Imaging, Nursing Assistant, Pit and Fissure Sealant, California Dental Practice Act, Infection Control, Radiation Safety, Teaching Adult Learner, Coronal Polishing, Dispensary Agent Certification, Vocational Nursing Pre-Requisite, LVN IV Therapy Certificate, and Emergency Medical Technician Certification. It also offers Computer Specialist: Accounting, Surgical Technology Associate of Applied Science Degree Program, Sterile Processing Technician, Computer Accounting and Business Administrative Specialist Certificate Program, Bachelor of Science in Nursing (RN to BSN), and EKG/ECG Technician programs. The company operates through academic institutions, including High Desert Medical College, Central Coast College, Contra Costa Medical Career College, and Integrity College of Health. Legacy Education Inc. was founded in 2009 and is headquartered in Lancaster, California.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine LGCY's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Education
Industry Rating
B
LGCY
Ranked#10 of 27
Ranked#10 of 27
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $53.53 | A | |
| $32.98 | B | |
| $44.44 | B |
Be the first to know about important LGCY news, forecast changes, insider trades & much more!
LGCY News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how LGCY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
LGCY ($11.03) is overvalued by 78.07% relative to our estimate of its Fair Value price of $6.19 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
LGCY ($11.03) is not significantly undervalued (78.07%) relative to our estimate of its Fair Value price of $6.19 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
LGCY ($11.03) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more LGCY due diligence checks available for Premium users.
Valuation
LGCY fair value
Fair Value of LGCY stock based on Discounted Cash Flow (DCF)
Price
$11.03
Fair Value
$6.19
Overvalued by
78.07%
LGCY ($11.03) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
LGCY ($11.03) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
LGCY ($11.03) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
LGCY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
16.46x
Industry
17.95x
Market
8.79x
LGCY is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
LGCY is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
LGCY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.82x
Industry
2.04x
LGCY is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
LGCY price to earnings growth (PEG)
For valuing profitable companies with growth potential
LGCY is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
LGCY's financial health
Profit margin
Revenue
$21.4M
Net Income
$3.0M
Profit Margin
14.2%
LGCY's Earnings (EBIT) of $12.43M... subscribe to Premium to read more.
Interest Coverage Financials
LGCY's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$75.5M
Liabilities
$25.9M
Debt to equity
0.52
LGCY's short-term assets ($43.97M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LGCY's short-term assets ($43.97M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LGCY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$764.4k
Investing
-$248.6k
Financing
$108.0k
LGCY's operating cash flow ($5.88M)... subscribe to Premium to read more.
Debt Coverage Financials
LGCY vs Education Stocks
Legacy Education Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.